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Abstract
Embryo aggregation has been demonstrated to improve cloning efficiency in mammals. However, since no more than three
embryos have been used for aggregation, the effect of using a larger number of cloned zygotes is unknown. Therefore, the
goal of the present study was to determine whether increased numbers of cloned aggregated zygotes results in improved
in vitro and in vivo embryo development in the equine. Zona-free reconstructed embryos (ZFRE’s) were cultured in the well
of the well system in four different experimental groups: I. 1x, only one ZFRE per microwell; II. 3x, three per microwell; III. 4x,
four per microwell; and IV. 5x, five ZFRE’s per microwell. Embryo size was measured on day 7, after which blastocysts from
each experimental group were either a) maintained in culture from day 8 until day 16 to follow their growth rates, b) fixed
to measure DNA fragmentation using the TUNEL assay, or c) transferred to synchronized mares. A higher blastocyst rate was
observed on day 7 in the 4x group than in the 5x group. Non-aggregated embryos were smaller on day 8 compared to
those aggregated, but from then on the in vitro growth was not different among experimental groups. Apoptotic cells
averaged 10% of total cells of day 8 blastocysts, independently of embryo aggregation. Only pregnancies resulting from the
aggregation of up to four embryos per microwell went beyond the fifth month of gestation, and two of these pregnancies,
derived from experimental groups 3x and 4x, resulted in live cloned foals. In summary, we showed that the in vitro and in
vivo development of cloned zona-free embryos improved until the aggregation of four zygotes and declined when five
reconstructed zygotes were aggregated.
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Introduction
To date, many equine clones have been reported; however,
cloning efficiency remains low [1–9]. Research is hampered in this
species by the limited number of slaughterhouses and low recovery
rates of oocytes by transvaginal aspiration.
As a means to improve cloning efficiency, the strategy of
embryo aggregation has been applied in several species. These
include the mouse [10], [11], bovine [12–14], pig [15] and horse
[8]. These studies have reported benefits of embryo aggregation
for in vitro and/or in vivo embryo development. In addition,
embryo aggregation has been successfully used for chimera
production [16–23], and to improve the establishment of
parthenogenetic stem cells and the expression of imprinted genes
[24].
The aggregation of two or three embryos at the onset of cloned
embryo development could compensate for epigenetic defects of
individual cells with different reprogramming status. This appears
to be one reason for the improved developmental competence of
aggregated embryos [10,25]. Furthermore, despite the fact that
aggregated embryos are larger on day 7, after day 8 they are no
different from non-aggregated embryos [8]. To elucidate this
intriguing fact, mechanisms such as apoptosis must be studied.
Apoptosis is a cellular mechanism that controls cell numbers
during embryonic development and levels of apoptotic cells can be
used as an indicator of embryo quality [26–30]. To date, apoptosis
levels have been measured in the horse by the TUNEL assay for
both ICSI embryos and for those produced in vivo [31], [32].
The aim of this work was to determine whether the number of
aggregated zygotes changes the aggregation strategy efficiency. Up
to five equine clones were aggregated and the in vitro and in vivo
embryo development were evaluated. In addition, the effect of
aggregation on embryo quality was measured by evaluating
blastocyst size, DNA fragmentation levels, in vitro embryo growth
beyond day 8 and the establishment of pregnancies and cloned
foal production.
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Materials and Methods
Chemicals
Except otherwise indicated, all chemicals were obtained from
Sigma Chemicals Company (St. Louis, MO, USA).
Animal Welfare
All the research protocols were in accordance with the
recommendations of the guidelines stated in the Guide for the
Care and Use of Agricultural Animals in Agricultural Research
and Teaching. The study design was approved by the Ethics and
Animal Welfare Committee for the Faculty of Agriculture,
University of Buenos Aires under number CEyBAFAUBA2014/
1. All efforts were made to minimize animal suffering. All animals
were housed at ‘‘Don Antonio’’ equine center in Buenos Aires,
Argentina. Trained people provided daily care and feeding, and
horses had permanent ad-libitum access to water. Recipient
palpations, ultrasounds, hormone treatments and embryo transfer
procedures were always performed by trained veterinarians.
Cell culture
Fibroblasts were obtained by culture of skin biopsies from an
Argentinean Polo Pony (donor cell A) and a Show-jumping horse
(donor cell B). They were cultured in Dulbecco’s modified Eagle’s
Medium (DMEM; 11885, Gibco, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum (FBS; 10499-044,
Gibco), 1% antibiotic–antimycotic (ATB; 15240-096, Gibco), and
1 ml/ml insulin-transferrin-selenium (ITS; 51300-044, Gibco) in
6.5% CO2 in humidified air at 39uC. After establishment of the
primary culture, fibroblasts were expanded, frozen in DMEM with
20% FBS and 10% DMSO, and stored in liquid nitrogen. Donor
cells were induced into quiescence by being grown to confluence.
Cells were trypsinized before use and resuspended in TALP-H
with 10% FBS.
Oocyte collection and in vitro maturation
Slaughterhouse ovaries were collected and transported to the
laboratory within 4–7 h, at 26–28uC. Equine oocyte recovery was
performed by a combination of scraping and washing of all visible
follicles using a syringe filled with DMEM/Nutrient Mixture F-12
medium (DMEM/F12; D8062), supplemented with 20 IU mL-1
heparin (H3149). Oocytes were matured for 24–26 h in 100 ml
microdrops of bicarbonate-buffered TCM-199 (31100-035; Gibco)
supplemented with 10% FBS, 2.5 mL/mL ITS, 1 mM sodium
pyruvate (P2256), 100 mM cysteamine (M9768), 0.1 mg/mL of
follicle-stimulating hormone (NIH-FSH-P1, Folltropin; Bioniche,
Belleville, ON, Canada) and 1% ATB, under mineral oil (M8410).
Maturation conditions were 6.5% CO2 in humidified air at 39uC.
Cumulus and zona pellucida removal
Cumulus cells were removed by a combined treatment of
pipeting oocytes in 0.05% Trypsin-EDTA (25300, Gibco) and
vortexing them for 2 minutes in hyaluronidase [H4272; 1 mg/mL
in Hepes-buffered Tyrodes medium containing albumin, lactate
and pyruvate (TALP-H)]. Oocytes were individually observed
under stereoscopic microscopy to confirm the presence of the first
polar body.
In order to prepare the metaphase II oocytes for enucleation,
the zona pellucida was removed by incubating oocytes for 3–6 min
in 1.5 mg/ml pronase (P8811) in TALP-H on a warm plate. Zona-
free oocytes (ZF-oocytes) were rinsed in TALP-H and placed in a
microdrop of Synthetic Oviductal Fluid (SOF), supplemented with
2.5% FBS and 1% ATB, until enucleation.
Oocyte enucleation
Aspiration of the metaphase plate was performed in a
microdrop of TALP-H containing 0.5 mg/ml of cytochalasin B
(C6762). A blunt pipette was used for the aspiration, and a closed
holding pipette to support the oocyte during the procedure. In
order to observe the metaphase plate under UV light, ZF-oocytes
were incubated (5 min), prior to enucleation, in a microdrop of
SOF containing 1 mg/mL Hoechst bisbenzimide 33342 (H33342).
Zona-free enucleated oocytes (ZFE-oocytes) were kept in a SOF
microdrop until nuclear transfer.
Nuclear transfer and cloned embryo reconstruction
Zona-free enucleated oocytes were individually washed for a few
seconds in 50 ml drops of 1 mg/ml phytohemagglutinin (L8754)
dissolved in TCM-Hepes, and then dropped over a donor cell
resting on the bottom of a 100 ml TALP-H drop; consequently
these two structures were attached. Formed cell couplets were
washed in fusion medium [0.3 M mannitol (M9546), 0.1 mM
MgSO4 (M7506), 0.05 mM CaCl2 (C7902), 1 mg/ml polyvinyl
alcohol (P8136)], and then fused in a fusion chamber containing
2 ml of warm fusion medium. A double direct current pulse of
1.2 kV/cm V, each pulse for 30 ms, 0.1 s apart was utilized for
fusion. Couplets were individually placed in a 10 ml drop of SOF
medium supplemented with 2.5% FBS and incubated under
mineral oil, at 39uC in 5% CO2 in air. Twenty minutes after the
first round of fusion, non-fused couplets were re-fused.
Chemical activation
Two hours after the first round of fusion, zona-free recon-
structed embryos (ZFRE’s) were subjected to chemical activation.
Chemical activation was achieved by a 4 min treatment in TALP-
H containing 8.7 mM ionomycin (I24222; Invitrogen, Carlsbad,
CA, USA) followed by a 4 h individual culture in a 5 ml drop of
SOF supplemented with 1 mM 6-dimethylaminopurine (D2629)
and 5 mg/ml cycloheximide (C7698).
In vitro embryo culture until day 8 and embryo
aggregation
In vitro culture of ZFRE’s was carried out in microwells
containing 50 ml microdrops of DMEM/F12 medium under
mineral oil. These microwells were produced using a heated glass
capillary lightly pressed to the bottom of a 35 x 10 mm Petri dish.
Four different experimental groups were set up according to the
number of ZFRE’s placed per each microwell: I. Group 1x: one
ZFRE per microwell (non aggregated embryos), II. Group 3x:
three ZFRE’s per microwell, III. Group 4x: four ZFRE’s per
microwell, IV. Group 5x: five ZFRE’s per microwell. Culture
conditions were 5% O2, 5% CO2 and 90% N2 in a humidified
atmosphere at 38.5uC. Half of the medium was renewed on Day 3,
with DMEM/F-12 HAM medium containing 10% FBS, and 1%
ATB. A similar ratio of ZFRE’s/culture medium was maintained
for all experimental groups. Cleavage was assessed 72 h after
activation, and rates of blastocyst formation and their diameter
were recorded at Day 7 and Day 8 when the embryos were either
fixed for TUNEL assay, maintained in in vitro culture or
transferred to synchronized mares.
In vitro embryo culture beyond day 8
Fourteen derived B donor cell blastocysts from all experimental
groups were kept in in vitro culture from day 8 until day 16–17
unless they collapsed earlier. One blastocyst from the 4x
experimental group was found collapsed on day 15 and was not
included for apoptosis analysis. On day 12, blastocysts were placed
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in a fresh 100 ml microdrop of DMEM/F12 medium containing
15% FBS and 1% ATB. Blastocyst diameters were measured daily
using a millimeter eyepiece. At day 16, embryos were fixed for
TUNEL assay.
Embryo fixing and TUNEL assay
DNA fragmentation was evaluated using the DeadEnd Fluoro-
metric TUNEL System (Promega G3250, Madison, WI, USA).
Embryos were fixed in 4% paraformaldehyde in DPBS, washed in
BSA (A7906) solution (1 mg BSA/ml DPBS), permeabilized with
0.5% Triton X-100 in DPBS for 15 min at room temperature, and
rinsed again in BSA solution. After three washes, embryos were
incubated in the dark for 2 h at 39uC in a buffer consisting of
equilibration buffer and a nucleotide mix containing fluorescein-
dUTP and terminal deoxynucleotidyl transferase. Negative
controls lacked the terminal deoxynucleotidyl transferase. The
nuclei were counterstained with 0.5% propidium iodide for
30 min at room temperature. Embryos were washed in BSA
solution and mounted on a glass slide in 70% v/v glycerol under a
coverslip. Embryos were analyzed on a Nikon Confocal C.1
scanning laser microscope. An excitation wavelength of 488 nm
was selected for detection of fluorescein-12-dUTP and a 544 nm
wavelength to excite propidium iodide. Images of serial optical
sections were recorded every 1.5–2 mm vertical step along the Z-
axis of each embryo. Three-dimensional images were constructed
using EZ-C1 3.9 software (Nikon Corporation, Japan). Total cell
numbers and DNA-fragmented nuclei were counted manually for
day 8 embryos. Due to the large number of cells of day 16
embryos, cells of five different areas of each day 16 blastocyst were
counted using the Image J software (1.47 version, Wayne Rasband
National Institutes of Health, USA).
Embryo transfer and production of cloned foals
Blastocyst transfers to recipients were performed during the
breeding season. Mares aged 3 to 10 years were examined 2–3
times/week by transrectal ultrasound (5MHz linear probe, Aloka
500) to determine the phase of their estrous cycle. Prostaglandin
F2 Alfa (Ciclase, Sintex, Buenos Aires, Argentina) and human
chorionic gonadotropin (Ovusyn, Sintex, Buenos Aires, Argentina)
were used to synchronize the day of ovulation. Transcervical
embryo transfer was performed 5 to 7 days after ovulation, with
one or two day 7 blastocysts. Blastocysts were transported in a 0.5
cc straw containing DMEM/F12, and the shipping container was
held at 36uC for the 3 h transportation interval. Pregnancies were
diagnosed by transrectal ultrasound 15 days after ovulation. At day
300 of gestation pregnant mares were moved to an equine hospital
(KAWELL, Equine Rehabilitation Center, Solı´s, Argentina) where
they were monitored until parturition.
DNA comparison
The cloned foals were confirmed by an external laboratory
(Laboratorio de Gene´tica Aplicada de la Sociedad Rural
Argentina, ISAG code 84535). Twenty eight loci were compared
using hair samples from each foal and its respective donor animal.
Statistical analysis
Differences among treatments in each experiment were
determined using GraphPad Prism software version 5. Blastocyst
rates, embryo size and pregnancy rates were analyzed by Chi-
square or Fisher’s exact test. TUNEL-positive cells were evaluated
with the Kruskal-Wallis non parametric test and Dunn’s post test.
The effect of treatment on in vitro embryo growth rates was
assessed by one-way within subjects (repeated measures) analysis of
variance. Multiple observations of embryo growth rates in the
same experimental units (embryo/days) constituted the within
subject factor. Post-hoc pairwise comparisons of mean growing
rates/days were performed by the Tukey Honestly Significant
Differences test.
Results
In vitro embryo development of aggregated cloned
equine embryos until day 8
A total of 765 ZFRE’s were produced and cultured in vitro in
four different experimental groups. Cleavage and blastocyst rates
on day 7 and day 8 per embryo (microwell) and per ZFRE were
recorded for all experimental groups (Table 1). A significant
improvement of blastocyst rates per embryo was observed on day
7 when numbers of aggregated zygotes were up to 4/well.
Furthermore, aggregation did not involve the use of additional
oocytes to obtain blastocysts, since no significant differences from
the control group were observed on day 7. On day 7, there were
fewer blastocysts in the 5x group per number of ZFRE’s compared
to the 4x experimental group but no significant differences were
found from the control group. The aggregation of four zygotes
resulted in the best rate of in vitro embryo development, whereas
when five reconstructed zygotes were aggregated embryo devel-
opment rates decreased. Additional data are available in Table S1
and Table S2 showing the in vitro cloned equine embryo
developmental competence per somatic donor cell. Embryo
aggregation showed a similar effect between donor cells. Diam-
eters of day 7 blastocysts are shown in Table 2. Cloned blastocyst
size was smaller when no embryo aggregation was used. During
zona-free embryo development some blastomeres were observed
to be sloughed off into the microwell. This situation was observed
in all experimental groups.
In vitro development of cloned blastocysts beyond day 8
In vitro growth rates of 14 cloned blastocysts (donor cell B) were
determined daily. Growth patterns were similar between aggre-
gated and non-aggregated groups. The number of embryos
analyzed per group were: 1x: (n = 3), 3x: (n = 4), 4x: (n = 4) and
5x (n = 3). Each embryo within each experimental group derived
from different replicates. Mean embryo sizes per day 6SD were:
Day 8, 130.12 mm 632.88; Day 9, 219.12 mm 676.32; Day 11,
489.44 mm 6265.32; Day 12, 713.72 mm 6391.91; Day 13,
954.55 mm 6327.34; Day 14, 1664.87 mm 6713.54; Day 15,
2212.20 mm 6783.32 and day 16, 2677.18 mm 6977.43.
Figure 1 shows an equine zona-free cloned blastocyst from the
3x experimental group during in vitro embryo culture.
DNA fragmentation levels in cloned equine aggregated
embryos on day 8 and day 16 by TUNEL assay
DNA fragmentation levels (mean 6 SEM) of day 8 and day 16
cloned embryos of all experimental groups are shown in Table 3.
There were no differences between groups, on day 8, in the levels
of fragmented DNA, with an average of 10% positive TUNEL
cells seen in all embryos (Figure 2). TUNEL-positive cells in day
8 embryos were: Group 1x (n = 6): 9.26%, 10.26%, 12.41%,
13.04%, 17.39% and 25.58%; Group 3x (n = 3): 8.97%, 9.43%
and 10.29%; Group 4x (n = 5): 3.62%, 9.04%, 10.61%, 11.63%
and 11.84%; and Group 5x (n = 2): 8.86% and 11.16%. There
were no differences between groups on day 16 in the levels of
fragmented DNA, with an average of 2.5% positive TUNEL cells
seen in all cloned embryos (Figure 3). TUNEL-positive cell
percentage of total cells counted per day 16 embryos and
experimental group were: Group 1x (n = 3): 4.23%, 3.64% and
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4.42%; Group 3x (n = 2): 3.35% and 0.33%; Group 4x (n = 3):
0.15%, 0.88% and 2.03%; and Group 5x (n = 3): 1.80%, 2.91%
and 4.79%. Additional data are available in Figure S1.
In vivo development of aggregated cloned equine
embryos
Embryo transfer, pregnancy and survival rates for all experi-
mental groups are shown in Table 4. Early pregnancy rates were
higher when aggregated embryos were transferred; however, no
statistical differences were found in pregnancy rates between non-
aggregated and aggregated groups. Only pregnancies resulting
from the aggregation of up to four embryos per well survived
beyond the fifth month of gestation. One of the pregnant mares
from the 3x experimental group showed clinical signs of Equine
Metabolic Syndrome, dying in the last month of gestation. The
cloned fetus presented normal vital parameters until the death of
the mare. The two cloned foals obtained in this study derived from
experimental groups 3x and 4x (Figure 4). Their gestation times
were normal.
Both foals needed neonatology assistance and they responded
positively to treatment (oxygen, antibiotics and parental nutrition).
The cloned foal derived from experimental group 3x presented a
high degree of angular and flexural forelimb deformities.
Discussion
This study analyzed the effect of an increase in the numbers of
aggregated zygotes on in vitro and in vivo cloned embryo
development in the equine. Embryo aggregation has previously
proved to enhance the efficiency of cloning. However, to date,
studies on mammalian cloned embryo aggregation have focused
on determining the effect of the aggregation of a maximum of
three zygotes on in vitro and in vivo embryo production [8], [10–
14], [25], [33–36].
In vitro embryo development of aggregated embryos
until day 8
The aggregation of three and four embryos per microwell
improved blastocyst rates on a per embryo basis. Unexpectedly,
blastocyst development in the 5x experimental group at day 7 was
not improved over that of the 4x experimental group, and
blastocyst rates were similar to those obtained in the 3x
experimental group. Furthermore, as we have previously demon-
strated [8], embryo aggregation also enhanced blastocyst diame-
ters on day 7. If the positive effects of embryo aggregation are due
to an epigenetic compensation and/or an increase in embryo cell
number [10], [13], [15], [25], then an increase in the number of
aggregated zygotes should correlate to an improvement in in vitro
embryo development. Some of the reported benefits of embryo
aggregation are related to a normalization of gene expression and
developmental potential [10], [11], [37], an increase in cell
number [10], [12], [33] and a consequent improvement in
blastocyst development rates [10], [13], [33]. Additionally, the
lower results of the 5x experimental group indicate that these
benefits are related to the number of aggregated zygotes. Possible
mechanisms to explain this could be associated to an altered
microenvironment inside the microwell, limited capability of the
embryo to incorporate cells during embryo development or to
alterations in cell cycle or cell death.
Each microwell provides a particular microenvironment
reported to be beneficial for the embryo [38–40]. Embryo
aggregation may induce modifications in this microenvironment
leading to positive or negative effects depending on the number of
reconstructed zygotes placed per microwell. In addition, the effect
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of embryo culture density has been reported to alter embryo
development [40], [41]; furthermore in the bovine, the distance
between individual embryos in culture has been shown to
influence preimplantation development [42]. Therefore, placing
an excessive number of embryos per microwell could negatively
affect the microenvironment of the microwell and consequently
the developmental capability of aggregated embryos. In addition,
when aggregation is performed, the individual capability of each
ZFRE to produce a blastocyst is lost. The maximum blastocyst
rate per ZFRE when 5x aggregation is performed is 20%. As this
maximum value was not reached, we do not consider this a reason
for the reduced developmental competence of this experimental
group.
The high number of initial reconstructed zygotes of the 5x
group could impact negatively on embryo development. It has
been suggested that cell proliferation is a competitive process that
allows recognition and elimination of defective cells during the
early stages of development [43]. However, this situation could be
altered with an excessive number of embryo cells. Furthermore,
the developmental kinetics of in vitro-produced embryos is related
to their developmental competence [44], and can be affected by
the volume of the cytoplasm of the initial oocyte [45]. Even though
Table 2. Effects of equine cloned embryo aggregation on in vitro embryo size at day 7.
Blastocyst diameter
Experimental groups No. blastocyst 80–119 mm (%) 120–169 mm (%) 180–219 mm (%) 230–269 mm (%) $270 mm (%)
1x 13 8 (61.54)a 4 (30.77)ac 1 (7.69)a 0 (0)a 0 (0)a
3x 25 6 (24.00)b 4 (16.00)a 11 (44.00)b 3 (12.00)a 1 (4.00)a
4x 35 10 (28.57)b 7 (20.00)a 14 (40.00)b 3 (8.57)a 1(2.86)a
5x 7 0 (0)b 5 (71.43)bc 1 (14.29)ab 1 (14.29)a 0 (0)a
Total 80 26 (32.50) 20 (25.0) 25 (31.25) 7 (8.75) 2 (2.50)
Values with different superscripts in a column are significantly different (Fisher’s exact test P,0.05) (a, b).
doi:10.1371/journal.pone.0110998.t002
Figure 1. Photographs of an equine cloned aggregated blastocyst in in vitro embryo culture beyond day 8. An equine cloned zona free
blastocyst placed in a 100 ml drop of DMEM/F12 medium derived from the experimental group 3x during in vitro embryo culture from day 8 until day
16. (A) Day 9, 195.21 mm. (B) Day 10, 314.28 mm. (C) Day 11 444.75 mm. (D) Day 12, 498.76 mm. (E) Day 13, 672.17 mm. (F) Day 14, 1127.98 mm.
doi:10.1371/journal.pone.0110998.g001
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embryo aggregation does not imply an increase in the cytoplasm-
nucleus ratio, an increased embryo volume could also alter
embryo developmental kinetics and the developmental compe-
tence of aggregated embryos. In addition, a study suggested that
the length of the cell cycle can be regulated in the early post-
implantation mouse chimeric embryo in order to compensate for
increased pre-implantation cell numbers induced by aggregation
[46].
In vitro embryo development beyond day 8
Day 8 cultured blastocysts expanded and their cell numbers
increased; however, no statistical differences were observed among
experimental groups. Previous studies in mice revealed that size
regulation occurred in aggregated chimeric embryos during the
early post-implantation stage [46]. Moreover, despite the abnor-
mal proportions of ICM and trophectoderm in 4x aggregated
chimeric mice blastocysts, the proportions of the tissues derived
from them is already normal by day 5 [47]. Our observations
together with those previously reported [8] support the notion that
size regulation of aggregated cloned equine embryos occurs in the
pre-implantation stages.
In vitro embryo development after day 8 allows the study of
embryo developmental competence in a controlled environment
avoiding the disadvantages associated with embryo transfer.
Among domestic animals, in vitro development of embryos after
reaching the blastocyst stage has been studied in the bovine [48–
54] and porcine [51]. In the present study, the zona-free cloned
blastocyst maintained its spherical shape (see Figure 1). It has
been suggested that the embryo capsule is largely responsible for
maintaining the spherical shape of the conceptus in the equine
after day 6 [55]. Nevertheless, a capsule could not be clearly
identified by microscopy in any experimental group. Thus, if
present, it must be deficient. Alterations in early embryonic coats
have been reported for equine ICSI [56] and cloned embryos [8]
and also for rabbit [57]. Hence, improvements in in vitro culture
conditions are necessary to allow for the normal formation of early
embryonic coats in this species.
DNA fragmentation levels of aggregated cloned equine
embryos
Regardless of the fact that aggregated embryos began their
development with more cells, DNA fragmentation levels in cloned
blastocysts on day 8 were the same among experimental groups,
with an average of 10% of cells being apoptotic. Thus, at this stage
of development, the beneficial effects of embryo aggregation would
not be related to an anti-apoptotic phenomenon in the horse. This
contrasts with recent observations in pigs that indicate that embryo
aggregation has an anti-apoptotic effect due to fewer numbers of
apoptotic cells [34]. Species differences in embryo physiology such
as in the number of embryonic cells could be related to the effects
of embryo aggregation. On the other hand, size regulation of
aggregated chimeric mouse embryos was reported to be not
related to cell death since more than 90% of the cells were
synthesizing DNA and were presumably viable [46].
Apoptosis may have detrimental effects if either the number of
apoptotic cells or the proportion of these cells are elevated [58]. In
the equine, in vivo embryos recovered on day 6 did not show
apoptotic cells, while 4% of cells had fragmented DNA in in vitro
embryos produced by ICSI [32]. Consequently, the higher
proportion of apoptotic cells observed in our study could be a
reason for the lower developmental competence generally reported
for in vitro-produced equine embryos. A very interesting
observation was that day 16 embryos had a similar proportion
of apoptotic cells to day 8 embryos independently of aggregation.
Therefore, in vitro embryo culture in DMEM/F12 medium allows
embryo cell proliferation without inducing apoptosis.
In vivo embryo development of aggregated embryos
In this study, viable pregnancies resulted from the aggregation
of three and four reconstructed zygotes. In our previous
publication, embryo aggregation increased pregnancy rates for
cloned horses, being higher for 2x and even higher for 3x
aggregations [8]. Embryo aggregation of up to three zygotes also
improved pregnancy rates and in vivo embryo development in the
mouse [10] and bovine [60]. Nevertheless, the aggregation of
more than four cloned embryos did not improve pregnancy rates
in the present study. These observations agree with suggestions
previously reported [61] that the yield of live-born pups from
chimeric aggregation of five or more embryos would be low. On
the other hand, the abnormalities detected in the 3x cloned foals of
the present study have been reported in 50% of cloned foals [59],
indicating that angular and flexural limb deformities are not
induced by zona removal or embryo aggregation.
In conclusion, the data presented in this paper indicate that
cloned embryo aggregation in the equine results in increased
blastocyst rates at day 7 for the aggregation of up to 4 zygotes.
Table 3. Evaluation of DNA fragmentation levels in equine aggregated and non-aggregated cloned blastocysts at day 8 and day
16.
Blastocysts
Experimental
group No.
TUNEL+ cells
(Mean ±SEM)
Evaluated cells
(Mean ±SEM)
TUNEL+/evaluated
cells (Mean ±SEM)
Day 8 1x 6 26.8363.99 217.3651.92 14.6462.45
3x 3 21.8065.70 228.4652.88 9.3760.25
4x 5 39.2068.38 427.8665.28 9.3461.51
5x 2 25.0061.00 252.0619.00 10.0161.15
Day 16 1x 3 38.67615.30 963.76383.6 4.0960.23
3x 2 58.00654.00 21636962.5 1.8361.5
4x 3 48.67622.38 461861207 1.0260.54
5x 3 56.33612.20 20386788.0 3.1660.87
No significant differences were detected within blastocyst day (Kruskal-Wallis test P,0.05).
doi:10.1371/journal.pone.0110998.t003
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Beyond four reconstructed zygotes, blastocyst rates do not
continue to increase. Aggregated cloned embryos were initially
larger, but in vitro embryo size compensated after day 8 as we
have previously reported. A similar proportion of apoptotic cells
was observed on day 8 in all experimental groups, and this
phenomenon does not appear to be responsible for the observed
compensation. Only aggregated embryos from groups 3x and 4x
produced cloned offspring. This is the first report to show that the
in vitro and in vivo development of cloned zona-free embryos can
be improved when up to four zygotes are aggregated.
Figure 2. Photomicrographs of day 8 equine cloned embryo
expression of TUNEL. (A, B, C) Day 8 Non-aggregated cloned equine
embryo, 40x zoom. (D, E, F) Day 8 3x aggregated cloned embryo, 40x
zoom. (G, H, I) Day 8 4x aggregated cloned embryo, 40x zoom. (J, K,
M) Day 8 5x aggregated cloned embryo, 40x zoom.
doi:10.1371/journal.pone.0110998.g002
Figure 3. Photomicrographs of day 16 equine cloned embryo
expression of TUNEL. (A, B, C) Day 16 Non-aggregated cloned
equine embryo, 20x zoom. (D, E, F) Day 16 3x aggregated cloned
embryo, 20x zoom. (G, H, I) Day 16 4x aggregated cloned embryo, 20x
zoom. (J, K, M) Day 16 5x aggregated cloned embryo, 20x zoom.
doi:10.1371/journal.pone.0110998.g003
Table 4. Effects of equine cloned embryo aggregation on in vivo development.
Pregnancy Dynamic
Experimental
Groups
No. of
Recipient
Pregnant
recipients (%)
1st month
no. (%)
5th month
no. (%)
8th month
no. (%)
No. offspring
(%)
1x 10 1 (10.00) 1 (100.00) 0 (0) 0 (0) 0 (0)
3x 17 3 (17.64) 2 (66.66) 2 (66.66) 2 (66.66)* 1 (33.33)
4x 11 2 (18.18) 1 (50.00) 1 (50.00) 1 (50.00) 1 (50.00)
5x 5 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 44 6 (13.95) 4 (66.66) 3 (50.00) 3 (50.00) 2 (33.33)
No significant differences were found (Fisher’s exact test P,0.05). *One pregnant mare died of Equine Metabolic Syndrome.
doi:10.1371/journal.pone.0110998.t004
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Supporting Information Legends
Figure S1 Scatter plot of TUNEL positive cells propor-
tion in cloned equine blastocysts. (A) Day 8 blastocysts mean
TUNEL-positive cells of groups 1x, 3x, 4x and 5x. (B) Day 16
blastocysts mean TUNEL-positive cells of groups 1x, 3x, 4x and
5x.
(TIFF)
Table S1 Effects of equine cloned embryo aggregation
on in vitro development until day 8. Donor Cell A.
(DOCX)
Table S2 Effects of equine cloned embryo aggregation
on in vitro development until day 8. Donor Cell B.
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